logo
logo

EurekaBio raised $40M in a Series B+ funding led by Yeuxiu Industrial Fund to support the commercialization of its EuLV™ Lentiviral Vector Production System.

EurekaBio raised $40M in a Series B+ funding led by Yeuxiu Industrial Fund to support the commercialization of its EuLV™ Lentiviral Vector Production System.

03/10/24, 8:22 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/CN.svgshenzhen
Money raised
$40 million
Industry
biotechnology
Round Type
series b
Investors
Us Funds, China Funds, Yeuxiu Industrial Fund
EurekaBio closed a $40 million Series B+ funding led by Yeuxiu Industrial Fund to support the commercialization of its EuLV™ Lentiviral Vector Production System, a technology that the company believes could transform large-scale production of lentiviral vectors.

Company Info

Company
EurekaBio
Location
shenzhen, guangdong province, china
Additional Info
EurekaBio is a biotechnology company focusing on developing the EuLV™ Lentiviral Vector Production System for large-scale production of lentiviral vectors.

Related People